Differences in the management of hypertension, diabetes mellitus and dyslipidemia between obesity classes

被引:2
|
作者
Martinez-St John, D. R. J. [1 ]
Palazon-Bru, A. [1 ,2 ]
Gil-Guillen, V. F. [1 ,2 ]
Sepehri, A. [1 ]
Navarro-Cremades, F. [1 ]
Orozco-Beltran, D. [1 ]
Carratala-Munuera, C. [1 ]
Cortes, E. [3 ]
Rizo-Baeza, M. M. [4 ]
机构
[1] Miguel Hernandez Univ, Dept Clin Med, Alacant 03550, Spain
[2] Elda Hosp, Res Unit, Elda, Spain
[3] Miguel Hernandez Univ, Dept Pharmacol Pediat & Organ Chem, Alacant 03550, Spain
[4] Univ Alicante, Dept Nursing, Alacant, Spain
关键词
CLINICAL INERTIA;
D O I
10.1038/jhh.2015.29
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We did not find any paper that assessed clinical inertia in obese patients. Therefore, no paper has compared the clinical inertia rates between morbidly and nonmorbidly obese patients. A cross-sectional observational study was carried out. We analysed 8687 obese patients >= 40 years of age who attended their health-care center for a checkup as part of a preventive program. The outcome was morbid obesity. Secondary variables were as follows: failure in the management of high blood pressure (HBP), high blood cholesterol (HBC) and high fasting blood glucose (HFBG); gender; personal history of hypertension, dyslipidemia, diabetes, smoking and cardiovascular disease; and age (years). We analysed the association between failures and morbid obesity by calculating the adjusted odds ratio (OR). Of 8687 obese patients, 421 had morbid obesity (4.8%, 95% confidence interval (CI): 4.4-5.3%). The prevalence rates for failures were as follows: HBP, 34.7%; HBC, 35.2%; and HFBG, 12.4%. Associated factors with morbid obesity related with failures were as follows: failure in the management of HBP (OR = 1.42, 95% CI: 1.15-1.74, P = 0.001); failure in the management of HBC (OR = 0.73, 95% CI: 0.58-0.91, P = 0.004); and failure in the management of HFBG (OR = 2.24, 95% CI: 1.66-3.03, P < 0.001). Morbidly obese patients faced worse management for HBP and HFBG, and better management for HBC. It would be interesting to integrate alarm systems to avoid this problem.
引用
收藏
页码:7 / 10
页数:4
相关论文
共 50 条
  • [1] Differences in the management of hypertension, diabetes mellitus and dyslipidemia between obesity classes
    D R J Martínez-St John
    A Palazón-Bru
    V F Gil-Guillén
    A Sepehri
    F Navarro-Cremades
    D Orozco-Beltrán
    C Carratalá-Munuera
    E Cortés
    M M Rizo-Baeza
    [J]. Journal of Human Hypertension, 2016, 30 : 7 - 10
  • [2] Primary care management of hypertension and dyslipidemia in individuals with diabetes mellitus
    Mazze, R
    Bergenstal, R
    Simonson, G
    Strock, E
    Acton, K
    [J]. DIABETOLOGIA, 1997, 40 : 2596 - 2596
  • [3] The treatment of hypertension and dyslipidemia in diabetes mellitus
    Fineberg, SE
    [J]. PRIMARY CARE, 1999, 26 (04): : 951 - +
  • [4] Association between psoriasis, diabetes mellitus, hypertension and obesity
    Mala, Priyanshu
    Bhattacharjee, Ila
    Bhattacharya, Gora Chand
    Ghosh, Sanjay
    Sarker, Gautam
    Pal, Ranabir
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2015, 3 (03): : 132 - 136
  • [5] Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition
    van den Berg, Esther
    Kloppenborg, Raoul P.
    Kessels, Roy P. C.
    Kappelle, L. Jaap
    Biessels, Geert Jan
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (05): : 470 - 481
  • [6] The association between psoriasis, diabetes mellitus, hypertension and obesity in India
    Aziz, T.
    Kumar, A. S.
    Madhu, B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 58 - 58
  • [7] Is there a relationship between endometrial polyps and obesity, diabetes mellitus, hypertension?
    Serhat, Esra
    Cogendez, Ebru
    Selcuk, Selcuk
    Asoglu, Mehmet Resit
    Arioglu, Petek F.
    Eren, Sadiye
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (05) : 937 - 941
  • [8] Is there a relationship between endometrial polyps and obesity, diabetes mellitus, hypertension?
    Esra Serhat
    Ebru Cogendez
    Selcuk Selcuk
    Mehmet Resit Asoglu
    Petek F. Arioglu
    Sadiye Eren
    [J]. Archives of Gynecology and Obstetrics, 2014, 290 : 937 - 941
  • [9] Prevalence of Obesity, Dyslipidemia and Diabetes Mellitus in Patients with Gastrojejunostomy
    Kumar, K. Sunil
    Sasidharan, Abhishek
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (05)
  • [10] Prevalence of Metabolic Syndrome in the Mediterranean Region of Turkey: Evaluation of Hypertension, Diabetes Mellitus, Obesity, and Dyslipidemia
    Guendogan, Kuersat
    Bayram, Fahri
    Capak, Mehmet
    Tanriverdi, Fatih
    Karaman, Ahmet
    Ozturk, Ahmet
    Altunbas, Hasan
    Goekce, Cumali
    Kalkan, Ali
    Yazici, Cevad
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (05) : 427 - 433